Conestoga Capital Advisors, an asset management company, released its second-quarter 2025 investor letter. A copy of the ...

Veeva Systems (VEEV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...

Veeva Systems reported fiscal first-quarter results Wednesday that beat expectations, but weren't too exciting. The stock soared in response to management's outlook, which implies stronger growth ...

Veeva Systems also added 13 new Vault CRM customers in the fiscal third quarter. In September, VEEV commented on the release of Veeva Site Connect, which is part of the Veeva Clinical Platform.

Veeva Systems (VEEV) recently experienced a 31% increase in share price over the last quarter, a period marked by significant developments for the company. Key to this movement was Merck's commitment ...

Buying $100 In VEEV: If an investor had bought $100 of VEEV stock 10 years ago, it would be worth $1,074.72 today based on a price of $292.60 for VEEV at the time of writing.

Veeva Systems has nearly tripled revenues and earnings over the past five years, but the stock's getting beaten down so badly that investors are starting to wonder if it's still a smart buy. ...

Summary. Veeva Systems is a cloud-based software solution provider for the pharmaceutical and life sciences industries. Veeva is valued at over $20 billion and is considered a top player in the ...

Life sciences CRM provider Veeva Systems this afternoon reported fiscal Q4 revenue and profit that topped analysts' expectations, and an outlook that for this quarter's revenue and profit higher ...

Shares of Veeva Systems (NYSE: VEEV) rose 12.8% in August, according to data provided by S&P Global Market Intelligence.The company reported excellent quarterly financial results, and the stock's ...

Shares of Veeva Systems (VEEV-1.17%) leapt about 6% on Thursday, March 2, following a fiscal-fourth-quarter earnings report that management announced the previous afternoon.